{"count": 1, "results": [{"_id": "18373914", "pmid": 18373914, "title": "[Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones].", "journal": "Med Clin (Barc)", "authors": ["Iglesias P", "Díez JJ"], "date": "2008-03-15T00:00:00Z", "doi": "10.1157/13117351", "meta_date_publication": "2008 Mar 15", "meta_volume": "130", "meta_issue": "9", "meta_pages": "345-50", "score": 50067.477, "text_hl": "Beta blockers, such as @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, and @CHEMICAL_Benzodiazepines @CHEMICAL_MESH:D001569 @@@benzodiazepines@@@ have been used as a symptomatic therapy. ", "citations": {"NLM": "Iglesias P, Díez JJ. [Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones]. Med Clin (Barc). 2008 Mar 15;130(9):345-50. PMID: 18373914", "BibTeX": "@article{18373914, title={[Therapeutic possibilities in patients with selective pituitary resistance to thyroid hormones].}, author={Iglesias P and Díez JJ}, journal={Med Clin (Barc)}, volume={130}, number={9}, pages={345-50}}"}}]}